Detalles de la búsqueda
1.
Population Pharmacokinetic-Pharmacodynamic Modeling of a Novel Methylphenidate Extended-Release Orally Disintegrating Tablet in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder.
J Clin Psychopharmacol
; 38(5): 467-474, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30119076
2.
Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 31(5): 342-349, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34081560
3.
A Single-Dose, Two-Way Crossover, Open-Label Bioequivalence Study of an Amphetamine Extended-Release Oral Suspension in Healthy Adults.
J Atten Disord
; 24(3): 414-419, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29192549
4.
An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children.
J Child Adolesc Psychopharmacol
; 30(1): 15-20, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31295008
5.
Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.
Clin Pharmacol Drug Dev
; 7(2): 160-167, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544344
6.
Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 28(1): 29-35, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28933918
7.
A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy Adults.
Clin Pharmacol Drug Dev
; 7(2): 151-159, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544581
8.
Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Clin Ther
; 39(12): 2389-2398, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174216
9.
Pharmacokinetics of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 27(3): 216-222, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27936898
10.
A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults.
Clin Ther
; 39(8): 1695-1705, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28760535
11.
Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
J Child Adolesc Psychopharmacol
; 27(1): 66-74, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27183299
12.
Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study.
Clin Ther
; 28(8): 1107-1115, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16982287
13.
A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.
Postgrad Med
; 128(7): 648-55, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27488574
14.
A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 26(6): 505-12, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27228207
15.
In vivo disintegration profiles of encapsulated and nonencapsulated sumatriptan: gamma scintigraphy in healthy volunteers.
J Clin Pharmacol
; 45(1): 101-5, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15601811
16.
HPA hyperactivity with increased plasma cortisol affects dexamethasone metabolism and DST outcome.
J Psychiatr Res
; 36(6): 417-21, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12393311
17.
How to Dose Attention-Deficit/Hyperactivity Disorder Medications Without a Grain of Salt.
J Child Adolesc Psychopharmacol
; 28(8): 576-577, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30085849
18.
Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.
J Clin Psychiatry
; 68(5): 711-20, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17503980
19.
Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis.
Headache
; 47(2): 181-8, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17300357
20.
Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
Headache
; 46(7): 1142-50, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16866718